Multicomponent Vascular Composition Stabilizing Patterns

The patent employs a composite formulation containing boric acid, aluminum sulfate, sodium chloride, potassium chloride, and chamomile extract. This multi-component composition works synergistically to address pathological neovascularization through multiple mechanisms: boric acid and aluminum sulfate provide vasoconstrictive and anti-proliferative effects, while chamomile extract contributes anti-inflammatory and antioxidant properties. The composite nature of the treatment allows it to tackle multiple aspects of the disease process simultaneously, improving overall treatment efficacy where single-agent therapies have failed.

The composition applies preliminary anti-action by using boric acid and aluminum sulfate to constrict blood vessels and inhibit endothelial cell proliferation before pathological neovascularization can progress to the stage of fragile, leaky vessels. By acting early in the pathological process, the treatment prevents the formation of abnormal vessels that would otherwise become fragile and cause hemorrhage. The chamomile extract simultaneously reduces inflammation that would exacerbate vessel damage, creating a protective effect against the harmful consequences of neovascularization.

The patent converts the harmful effect of elevated VEGF expression into a beneficial outcome by using aluminum sulfate and boric acid to modulate the angiogenic response. Instead of allowing uncontrolled VEGF-driven pathological neovascularization, the composition harnesses the body's natural angiogenic signaling while directing it toward controlled, functional vessel formation. The aluminum sulfate specifically inhibits VEGF-mediated endothelial proliferation, transforming the potentially harmful hypoxia-driven angiogenic burst into a controlled process that produces healthy, non-leaky vessels.